-
Acquisition of Bayer’s products gives Dhanuka foothold in important overseas markets
-
In the Year of the Snake, can Indian business find its innovation bite? Judging by its performance in 2024, the chances are slim
-
The volume of shareholder activism and dealmaking by private equity has mushroomed
-
It represents a big leap in Quantum Computing research but, as even Google admits, this is not likely to lead to even a small practical Quantum Computer by 2030
-
The NJ Bio acquisition follows Sapala Organics purchase in June
-
The development follows the approval of a resolution plan for Karkinos Healthcare by NCLT after it entered the Corporate Insolvency Resolution Process (CIRP) in May.
-
The IPO juggernaut continues as three new ones will open for subscription. The central banks of Australia, Canada and Euro Area will decide on interest rates
-
The merger will strengthen Aster’s position in Hyderabad and South India, but it also faces certain challenges.
-
The idea that putting more data into a bigger model will deliver smarter systems is starting to break down
-
Most monopolies in the technology world have been reduced to dust by startup business ideas using newer technologies. A push to divest it may spur Google to invest further in AI to diversify its business lines
-
The parent company’s hunger for protecting market leadership, accelerating growth as India’s economy transforms and rolling out parts of a global strategy locally could lead to better growth outcomes
-
Difficult business conditions and debt taken on for acquisitions are weighing down on its performance. The pace of earnings recovery and balance-sheet deleveraging will determine stock returns
-
The years of audit failings and regulatory fines at its UK business are over, but some worry the firm is still losing ground to rivals
-
2024 has been a record year for QIP fundraising, with 77 companies raising Rs 96,320.83 crore, as per data from primary market tracker Prime Database.
-
Om Manchanda, managing director of Lal PathLabs, is moving on to an advisory role after steering the company for close to two decades
-
-
The increase in divergence between Bloomberg consensus estimates for FY2025 and bottom up Nifty estimate shows lack of confidence on prospects of upgrades in the near term
-
For years, banks and NBFCs were engaged in an intense rivalry to grow their loan books, perhaps forgetting the cardinal rule of lending—assessing a borrower's creditworthiness. Probably, they are having to pay a price for it now
-
Sectors like semiconductors and AI can reshape — or, in some cases, conjure up entirely new — markets
-
The $250 billion contract research, development and manufacturing organisation (CRDMO) industry is expected to grow at nearly double the pace of the global pharma industry
-
X (Twitter), though combative in its vibe, is easier for company chiefs to use and bridge information gaps with customers
-
In today's edition of Pro Panorama: Hyundai's bumper IPO, making sense of Noel Tata's appointment, peeling off layers of IIP and much more
-
AI has made its way in boardrooms, triggering questions about their future role there. At best, AI is a tool that enhances the functioning of boards. Ethical dilemmas and decision making in the face of incomplete information, issues which boards grapple with, are beyond the grasp of Gen AI
-
Driven by a fire in his belly, he first took on the group’s legendary satraps and overcame them to bring a more coherent strategic approach that led to seeking opportunities everywhere. There were audacious experiments and purchases, not all of which succeeded. His appetite for risk was in sync with the environment created by India’s economic liberalisation when he took over the Tata Group
-
A world where the tech giant gets dismantled is more plausible than it was, but investors have reason to be unfazed
